Budesonide induces complete remission in autoimmune hepatitis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

522

HTML

3106

Figures (1-1)

266

Tables (1-2)

288

Sum=4182

Mar 7, 2006 (publication date) through Jan 27, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Viral Hepatitis

World J Gastroenterol. Mar 7, 2006; 12(9): 1362-1366
Published online Mar 7, 2006. doi: 10.3748/wjg.v12.i9.1362

Table 2 Patients receiving budesonide as second-line therapy

	Pre-budesonidetherapy PRD(mg/d)	AZA(mg/d)	URSO(mg/d)	Diagnosis	Side effects of PRD or AZA
Acute exacerbation of the disease
B.S.	0	100	0	AIH	no
D.H.	0	100	0	AIH-PBC	no
F.C.	0	100	0	AIH	no
G.W.	10	0	0	AIH-PBC	no
No response to PRD
S.H-D.	40	0	1000	AIH-PSC	Headache, hypertension
Side effects of the drugs
K.C.	10	100	0	AIH	Weight gain of 20 kg
B.R.	5	0	0	AIH	Osteoporosis, myopathy
S.U.	10	50	750	AIH-PSC	Pancreatitis

Citation: Csepregi A, Röcken C, Treiber G, Malfertheiner P. Budesonide induces complete remission in autoimmune hepatitis. World J Gastroenterol 2006; 12(9): 1362-1366
URL: https://www.wjgnet.com/1007-9327/full/v12/i9/1362.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i9.1362